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AbstrAct
Introduction Urban living has been shown to affect 
health in various ways. As the world is becoming more 
urbanised and almost two-thirds of people with diabetes 
now live in cities, research into the relationship between 
urban living, health and diabetes is key to improving the 
lives of many. The majority of people with diabetes have 
type 2 diabetes, a subset linked to overweight and obesity, 
decreased physical activity and unhealthy diets. Diabetes 
has significant consequences for those living with the 
condition as well as their families, relationships and wider 
society. Although care and management are improving, 
complications remain common, and diabetes is among 
the leading causes of vision loss, amputation, neuropathy 
and renal and cardiovascular disease worldwide. We 
present a research protocol for exploring the drivers of 
type 2 diabetes and its complications in urban settings 
through the Cities Changing Diabetes (CCD) partnership 
programme.
Methods and analysis A global study protocol is 
implemented in eight collaborating CCD partner cities. In 
each city, academic institutions, municipal representatives 
and local stakeholders collaborate to set research 
priorities and plan implementation of findings. Local 
academic teams execute the study following the global 
study protocol presented here. A quantitative Rule of 
Halves analysis obtains measures of the magnitude of 
the diabetes burden, the diagnosis rates in each city and 
the outcomes of care. A qualitative Diabetes Vulnerability 
Assessment explores the urban context in vulnerability to 
type 2 diabetes and identifies social factors and cultural 
determinants relevant to health, well-being and diabetes.
Ethics and dissemination The protocol steers the 
collection of primary and secondary data across the study 
sites. Research ethics board approval has been sought 
and obtained in each site. Findings from each of the local 
studies as well as the result from combined multisite 
(global) analyses will be reported in a series of core 
scientific journal papers.
IntroductIon
Today, 54% of the world’s population lives 
in areas which have, by custom or definition, 
come to be referred to as ‘urban’.1 Urban resi-
dence is estimated to increase to 66% in 2050, 
while the global population is forecasted to 
increase by 2.5 billion over the same period.1 
Much of the increase will be in developing 
countries, where the rate of urbanisation is 
most rapid.2 Demographic shifts from rural 
to urban areas are associated with many alter-
ations including changes in public hygiene, 
sanitation and access to healthcare and in 
occupational, dietary and physical activity 
patterns.3 These changes have fundamental 
implications for the emergence of non-com-
municable diseases,3 such as type 2 diabetes. 
Worldwide, 415 million adults are living with 
diabetes, corresponding to 8.8% of the global 
adult population.4 By 2040, the number is 
expected to rise to 642 million.4 Diabetes has 
considerable impact on mortality, disability 
as well as the lives of affected individuals 
and their families and presents a substantial 
cost for society. Diabetes-related costs are a 
significant economic burden and in 2015 
were estimated to account for 12% of global 
healthcare expenditure or US$673 billion. 
If projections hold true, cost will increase to 
over US$802 billion by 2040.4 Approximately 
90% of all people with diabetes have type 2 
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Protocol
strengths and limitations of this study
 ► Innovative, large-scale, in-depth data collection 
based on quantitative and qualitative methodologies.
 ► Diverse research sites contribute to global (overall) 
study findings while maintaining local research 
autonomy and ensuring relevance of findings.
 ► Study data from each city will not be absolutely 
comparable because of slightly differing local 
research needs and data collection/analysis 
strategies.
 ► Multisite research study involves data collection in 
five languages (Danish, Spanish, English, Italian, 
Mandarin, including various local dialects), meaning 
that especially qualitative data relies on accurate 
translation practices into study language (English).
 ► Studies are needed that compare rural versus 
urban, emerging mega cities versus declining urban 
economies,  economically unequal versus equal 
settings.
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diabetes, the development of which is impacted by risk 
factors such as excess body weight, physical inactivity, 
poor nutrition, ethnicity, family history of diabetes and 
increasing age.4
Almost two-thirds of all people with diabetes live in areas 
described as ‘urban’, and this is expected to increase to 
74% by 2040.4 Thus, it is important to identify which char-
acteristics of urban living impact health and well-being 
and to understand how they contribute to diabetes vulner-
ability or resilience. Some characteristics of urban living 
may increase the risk of disease, while others may offer 
protection;5 however, complex synergies of risk factors 
make it difficult to predict the exact impact of single 
factors in isolation. Furthermore, cities are complex and 
dynamic entities and each differs considerably in popula-
tion size, density, growth rate and so forth.
Most cities present a wide range of economic and 
social advantages and challenges,5 resulting in social 
and spatial inequalities6 that may also reflect broader 
national contexts. Differences between and within cities 
make it challenging to generalise on how urban life influ-
ences health. An example of this diversity of impact is 
shown in a study estimating multivariate adjusted ORs 
of known potential factors associated with diabetes in 
different income countries. ORs of having diabetes while 
living in urban areas were 1.07 in high-income coun-
tries (P=0.6511), 1.20 in upper-middle-income coun-
tries (P=0.0930), 1.20 in lower-middle-income countries 
(P=0.0284) and 1.65 in low-income countries (P<0.0001).7 
Interestingly, conventional risk factors such as age, body 
mass index (BMI), physical activity, diet, education 
and family history of diabetes did not fully account for 
the higher urban prevalence in low-income countries.7 
Thus, the authors hypothesised that social and cultural 
factors may be primary drivers of diabetes and those may 
compound the risk for the disease.7
In the context of this study, we differentiate between 
social factors and cultural determinants and draw on 
the general discourse around the social determinants of 
health and their role in creating health inequalities.8–10 
Traditionally, the social determinants of health encompass 
the structural conditions in a society, or, in other words, 
the ‘wider set of forces and systems shaping the condi-
tions of daily life’.11 These forces and systems include, 
among others, economic policies and systems, develop-
ment agendas, social policies and political systems which 
are commonly linked to notions of inequity and societal 
and individual health inequalities.11
Cultural determinants, on the other hand, are in fact 
often the foundation from which social factors emerge; 
for local practices and assumptions (at the individual, 
community or institutional levels) determine in part 
how social circumstances are created in the first place 
and, therefore, made sense of locally. By using the term 
‘cultural determinants’, we do not suggest that national, 
racial, ethnic or religious orientations determine health 
outcomes, but rather that the values, shared assump-
tions and conventional practices of groups determine 
the ethical, moral and behavioural foundations on which 
individual and collective decisions about health are made.
For example, in settings where gender inequality is a 
defining cultural feature of local society, a variety of social 
factors (eg, education level, access to work, economic 
equality and so forth) are also present and expressed and 
acted on accordingly. We, therefore, use the term culture 
in this protocol to refer to shared systems of value (both 
overt and covert) and their related conventions shared by 
groups of people in a given social context. Attitudes and 
beliefs, as well as ways of acting in and on one’s environ-
ment, are rooted in culture. Relating culture to human 
health and well-being makes it easier to understand how 
institutions, communities and individuals respond to a 
variety of factors that are of an environmental, geograph-
ical, political or economic nature.
rationale
There is a good knowledge base regarding the impact of 
biomedical and some socioeconomic factors relevant to 
diabetes. What has not yet been comprehensibly exam-
ined is how these factors interact with cultural and wider 
social components to mediate both the prevention and 
the experience of diabetes (and its precursors as well as 
complications) in urban settings, especially regarding the 
diagnostic process and long-term care provision.
There remains, in other words, a paucity of empirical 
studies that identify and examine the complex sociocul-
tural factors relevant to urban diabetes and that inte-
grate those factors into the wider biomedical context of 
diabetes treatment and prevention. What this means is 
that until now we have lacked an evidence base for the 
impact of lived experience on diabetes vulnerability and 
patterns of morbidity. This absence, we argue, has also 
prevented us from understanding local prevention and 
treatment needs, as well as local barriers to adherence. 
To address this paucity, we employ qualitative data collec-
tion and analysis methods directly based on, and linked 
to, quantitative data generated as part of the same study.
Aims and objectives
The research protocol presented here is designed to:
1. identify any gaps in the diagnosis and treatment 
pathways in a given research site through a quantitative 
Rule of Halves (RoH) analysis;
2. identify and explore vulnerabilities in a local popula-
tion as they relate to health, well-being and diabetes 
through a qualitative Vulnerability Assessment (VA);
3. establish a local evidence base in each study site by 
synthesising findings;
4. explore the impact of social factors and cultural 
determinants and their effect on individuals’ lives as 
well as diabetes vulnerability in specific urban settings 
around the world.
The protocol is designed for the Cities Changing 
Diabetes (CCD) programme, a cross-disciplinary and 
cross-sector public/private partnership established in 
2014 that follows recommendations from the 2013–2020 
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WHO Global Action Plan on Non-Communicable 
Diseases.
Research for the CCD programme is ongoing and 
conducted from 2015 until 2020. The programme aims 
to generate an understanding of the burden of diabetes 
and its social and cultural drivers in a growing number 
of partner cities. Academic institutions in each partner 
city generate site-specific evidence available to local city 
governments and stakeholders for building targeted 
interventions that can effectively address local drivers of 
diabetes. Local findings are shared within the programme 
and made available at a global level for other cities and 
stakeholders to build on.
The programme consists of three interrelated phases, 
which are described below.
Mapping: In this first phase, the city-specific diabetes 
burden and its sociocultural drivers are mapped, either 
using existing public health data or through a house-
hold survey. To date, eight cities are participating in 
the programme: Mexico City, Houston, Copenhagen, 
Shanghai and Tianjin were part of a first group and have 
completed the mapping phase; Vancouver and Johannes-
burg joined in 2016 and Rome in 2017. The three most 
recent cities to join the programme are currently in the 
mapping phase. Additional cities will participate by 2018. 
A body of collective knowledge about diabetes and its 
drivers in the participating cities is being generated.
Sharing: The results from the participating cities are 
continuously shared with city governments, academics, 
businesses, charitable organisations and others with an 
interest in healthy city planning and infrastructure, public 
health policies, and implementing novel interventions.
Action: Identifying and scaling up solutions to reduce 
the rate of diabetes in cities is the programme’s ultimate 
goal. In each city, local partners work together to develop 
and implement city-specific interventions based directly 
on the research results from the mapping phase. Such 
actions are expected also to inform cities other than those 
currently participating.
The global partnership consists of University College 
London (UCL), Steno Diabetes Center Copenhagen 
(SDCC) and Novo Nordisk (NN). UCL is the global 
academic lead for the overall research framework and 
advises local academic partners in designing and imple-
menting research protocols. SDCC contributes expertise 
in diabetes clinical epidemiology, registry studies and 
health promotion research. NN provides the programme 
management and has committed to fund the programme 
with US$20 million towards 2020. Cities interested in the 
CCD programme are encouraged to reach out to the 
global partnership.
Partner cities in the programme are each represented 
by a local partners group that consists of city govern-
ment(s), patient organisation(s), provider business(es) 
and academic institution(s). The total number of local 
partners varies from city to city. Each local partners group 
is responsible for local programme design and execu-
tion, setting the research framework, promoting diabetes 
advocacy and risk awareness and communication. Prog-
ress in programme implementation is discussed within 
the local partners groups and in dialogue with global 
partners and other participating cities through regular 
face-to-face and online meetings.
MEthods And AnAlysIs
Although many studies suggest a complex association 
between urban living and non-communicable diseases 
(both beneficial and detrimental to health), most of the 
published literature has not explored how and why cities 
affect health.5 The complexity of causation and the diver-
sity of mechanisms that may explain how characteristics 
of urban environments affect the health of people living 
there require large-scale, cross-disciplinary research 
focused on shaping population health.5
The research protocol presented in this paper, there-
fore, employs mixed-methods strategies to address this 
complexity and to explore the breadth and depth of the 
current status of diabetes in various cities around the 
globe. The quantitative research component consists of 
the RoH analysis and the qualitative research component, 
the VA, which together provide the foundation of the 
CCD research framework (figure 1).
rule of halves
The aim of the quantitative research is to generate  an 
overview of the diabetes burden in each city and iden-
tify the greatest challenges in relation to diagnosis and/
or treatment. This aim is achieved by estimating the 
so-called RoH (figure 2).12 13 The RoH is a theoretical 
framework used in various chronic diseases to measure 
levels of access to clinical care, adherence and effects of 
treatment. The first element of the RoH was suggested 
in the USA in 1947 for non-insulin-dependent diabetes14 
and in 1964 confirmed in the UK.15 The second element 
of the RoH for diabetes was added in 1976,16 and in 
1980, the third element was established.17 The RoH still 
largely holds true for many other chronic diseases.18 For 
this research, two additional elements are added to the 
RoH for  a total of five, stating that half the people with 
diabetes are not diagnosed, half of those diagnosed are 
not receiving care, half of those receiving care are not 
achieving treatment targets and half of those achieving 
treatment targets are not achieving the desired outcome 
(no complications).
local roh
Depending on available city data, local academic part-
ners agree with the local partners group and the global 
partners which methodology is optimal for establishing 
a local RoH baseline. The RoH can be estimated either 
through existing published research or by implementing 
new research including collecting blood samples, such as 
was the case in CCD partner Mexico City. The method-
ologies and results from each of the local RoHs will be 
published separately.
group.bmj.com on March 28, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
4 Napier AD, et al. BMJ Open 2017;7:e015240. doi:10.1136/bmjopen-2016-015240
Open Access 
Figure 1 The research framework.
Figure 2 The Rule of Halves theoretical framework.12
diabetes Vulnerability Assessment
The aim of the qualitative research is to study the specific 
social and cultural drivers that affect residents and that 
increase or decrease their diabetes vulnerability. The 
qualitative research is based on an established VA instru-
ment developed previously by the academic lead at UCL 
in collaboration with the United Nations.19 At the foun-
dation of a VA is the idea that addressing vulnerability 
depends on understanding the specific policy, social, 
cultural and individual conditions that impact life and 
well-being in any given field site. Regardless of the site and 
context of application, the VA examines: the combined 
effects on individual lives of social and environmental 
stressors; service use patterns and barriers; community 
structures; networks and adaptations (forms of social and 
cultural ‘capital’) and barriers to human agency and to 
social and cultural inclusion (vulnerability indicators). 
Data that characterises the complex ways in which vulner-
ability emerges is gathered in each of these areas, making 
it possible to identify levers that either increases risks or 
ameliorate their impact.
For the CCD programme, a global Diabetes Vulnera-
bility Assessment (D-VA) was designed by UCL based on 
the original VA instrument. The use of the D-VA improves 
understanding of the social, cultural and environmental 
characteristics that enhance or limit optimal health 
outcomes in relation to diabetes. The D-VA is a locally 
sustainable intervention tool because it builds on existing 
links to communities and stakeholders and creates new 
networks. The D-VA follows a set procedure (figure 3) 
and examines three general domains of inquiry: an 
external formal domain (assessing public assistance 
and programmes and use thereof); a local community 
domain (assessing local situations, responses and forms 
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Figure 3 The Diabetes Vulnerability Assessment (D-VA) procedure.
of adaptation and resilience) and a vulnerability domain 
(assessing barriers to individual capability and oppor-
tunity). This structure allows for replication in various 
settings, yielding the growing global database for vulnera-
bility factors in diabetes.
local d-VA
In each city, based on local and global group consensus, 
a target group for the VA is identified: either people diag-
nosed with type 2 diabetes and/or people at increased 
risk of developing type 2 diabetes.
Participant selection
Participants are recruited locally employing a purposive 
sampling technique. In line with qualitative research 
practices, such sampling makes possible the capturing of 
salient insights from target populations. Based on local 
and global team consensus, so-called case filters (eg, high 
BMI, living alone, living in a community without access 
to health insurance) ‘flag’ individuals in the local popu-
lation to be contacted for participation. In the first five 
cities, case filters were generated through statistical means 
(Houston) or were directly derived from existing data 
(Copenhagen). In others, where available data proved 
insufficient, global and local academic teams agreed 
on case filters for recruitment based on new research 
(Mexico City) or recruitment through community health 
centres and tertiary care facilities (Shanghai and Tianjin).
Application of the assessment and field worker training
In each city, the D-VA is tailored to the knowledge 
base and research capabilities of local academic part-
ners and revised in accordance with local language use 
and related health service and community structures. 
Data collection is carried out following the city-specific 
D-VA, which includes an interview guide consisting of 
approximately 75 closed and open-ended questions. 
The in-depth semistructured individual interviews are 
conducted by experienced field workers representing 
the local academic partner and trained by UCL in 
multiday workshops. Short pilots precede the data 
collection phase so as to allow for modifications of the 
interview protocol where needed. During data collec-
tion, field workers are discouraged from taking extensive 
notes so as to establish a rapport  with participants. All 
interviews are tape recorded, transcribed verbatim, and 
coded for analysis.
data analysis strategies
Data for analysis include verbatim interview transcripts 
(primary data) and basic demographic and biomedical 
information recorded for each interviewee. Furthermore, 
executive summaries of each interview with ethnographic 
observations and comments are drawn up by field workers 
(secondary data), and these are translated where neces-
sary. Executive summaries are based on a global template 
developed by UCL. So far, a total of 746 individual 
in-depth interviews have been conducted across the first 
five cities.
Primary data are coded and analysed by the specific 
local academic partner applying similar methodolo-
gies: Systematic Text Condensation20 in Copenhagen, 
Grounded Theory21 in Mexico City and Thematic 
Content Analysis (TCA)22–24 in Houston, Tianjin and 
Shanghai identifying relevant local social factors and 
cultural determinants that impact how health and 
well-being are experienced among individuals at local 
levels. The local methodologies will be presented in 
detail separately elsewhere.
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Secondary data are coded by UCL using TCA and with 
input from the respective local academic partner to 
analyse social factors and cultural determinants across 
cities. The global analysis runs along three parallel 
and complimentary trajectories. The first trajectory 
focuses on collating and analysing relevant local data 
sets following well-established TCA principles, making 
possible the identification of globally salient themes. 
The second trajectory focuses on synthesising the local 
findings into a set of social factors and cultural deter-
minants of diabetes that goes across the cities. In this 
way, a repository of social factors and cultural determi-
nants—locally and across cities— is established, which 
will evolve continuously as further data from addi-
tional cities are included. The third trajectory focuses 
on the development of locally useful case definitions 
of vulnerability that build on combinations of globally 
recognisable factors and local circumstances. These 
unique permutations of combined factors help guide 
local policy-makers in the application of resources for 
public health, urban planning and clinical and social 
services.
EthIcs And dIssEMInAtIon
The research in each city is conducted in accordance 
with the ethical principles of the Declaration of Helsinki. 
Informed written consent is obtained from participants. 
The respondents are anonymised and the personal data 
are only known to and protected by local academic part-
ners. Findings are presented in aggregated form. In addi-
tion, precautions are taken to ensure that no respondents 
are identifiable. As a regulatory requirement of Novo 
Nordisk, safety information from a participant relating to 
a Novo Nordisk product is reported within 24 hours.
The dissemination strategy of the research focuses 
on building bridges between participating cities and 
on sharing results with both academic and policy 
stakeholders.
 ► The first Global Cities Changing Diabetes Summit was 
held in Copenhagen in November 2015. Presentations 
and urban diabetes study results are available online. 
A second Global Summit took place in October  2017.
 ► The global research findings will be published sepa-
rately in peer-reviewed journals and presented at 
international conferences.
 ► The local research results from each city will be 
published separately in peer-reviewed national and 
international journals and presented at national and 
international conferences.
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